Clinical correlates of advanced retinopathy in type II diabetic patients: Implications for screening

Journal of Clinical Epidemiology

Volumn 49, Issue 6, 1996, Pages 679-685

  Delcourt, Cécile ^a   Villatte Cathelineau, Béryl ^b   Vauzelle Kervoedan, Françoise ^c   Papoz, Laure ^a   Bensoussan, D ^m   Fallas, P R ^m   Cuny, P ^d   Malinski, M ^d   Humbert, P ^d   Chopinet, P ^e   Perdoux, L ^e   Moyenin, P ^e   Grenier, J L ^f   Gross, P ^f   Malbrel, P ^f   Houlbert, D ^g   Langlois, J L ^g   Jellal, M ^b   Cathelineau, G ^b   Laurent, C ^m   Chagnon, A ^h   Pouget Abadie, J F ⁱ   Carre H ^m   Venot, J ^j   Cavigneaux Decourteix, I ^k   Violante, A ^l   Massabie, P ^l   Leid, J ^m   more..

^a Hopital Saint Charles   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c INSERM   (France)

^d Centre Hospitalier Regional De Metz Thionville   (France)

^e Centre Hospitalier de la Region d'Annecy   (France)

^f Hopital Victor Provo   (France)

^g Centre Hospitalier d'Alencon   (France)

^h Service de Soins de Longue Duree   (France)

ⁱ HÔPITAL DU BOCAGE   (France)

^j Centre Hospitalier de Saint Junien   (France)

^k LIMOGES UNIVERSITY HOSPITAL   (France)

^l Clinique Princess   (France)

^m Clinique Princess ^*

more..

Author keywords

Cross sectional; Nephropathy; Neuropathy; Non insulin dependent diabetes; Retinopathy; Screening

Indexed keywords

INSULIN;

ADULT; AGED; ARTICLE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; FEMALE; FLUORESCENCE ANGIOGRAPHY; FRANCE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTPATIENT; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; SCREENING TEST;

EID: 0029952743     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-4356(95)00582-X     Document Type: Article

References (51)

1. Lindstedt E. Causes of blindness in Sweden. Acta Ophthalmol 1969; 104 (Suppl.): 22-74.
2. Kahn HA, Hiller R. Blindness caused by diabetic retinopathy. Am J Ophthalmol 1974; 78: 58-67.
3. Sorsby A. The incidence and causes of blindness in England and Wales 1948-62. Report on Public Health and Medical Subjects No. 114. HMSO, London, 1966.
4. Ghafour IM, Allan D, Founds WS. Common causes of blindness and visual handicap in the west of Scotland. Br J Ophthalmol 1963; 67: 203-213.
5. Nicolosi A, Marighi PE, Rizzardi P, Osella A, Miglior S. Prevalence and causes of visual impairment in Italy. Int J Epidemiol 1994; 23: 359-364.
6. DRS Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report No. 8. Ophthalmology 1981; 88: 583-600.
7. DRS Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: The second report of Diabetic Retinopathy Study findings. Ophthalmology 1978; 85: 82-106.
8. ETDRS Research Group. Photocoagulation for diabetic macular edema. Early Treatment of Diabetic Retinopathy Study Report No. 1. Arch Ophthalmol 1985; 103: 1796-1806.
9. Herman WH, Teutsch SM, Sepe SJ, Sinnock P, Klein R. An approach to the prevention of blindness in diabetes. Diabetes Care 1983; 6: 608-613.
10. Position Statement. Screening for diabetic retinopathy. Guidelines of the American College of Physicians, American Diabetes Association and American Academy of Ophthalmology. Diabetes Care 1992; 15: 16-18.
11. Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabetic Med 1991; 8: 263-267.
12. Javitt JC, Canner JK, Frank RG, Steinwachs DM, Sommer A. Detecting and treating retinopathy in patients with diabetes mellitus. A Health Policy model. Ophthalmology 1990; 97: 483-495.
13. Javitt JC, Ferris FL, Aiello LP, Canner JK, Chiang Y, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Diabetes Care 1994; 17: 909-917.
14. Dasbach E, Fryback DG, Newcomb PA, Klein R, Klein BEK. Cost-effectiveness of strategies for detecting diabetic retinopathy. Med Care 1991; 29: 29-39.
15. Foulds WS, McCuish A, Barrie T, Green F, Scobie IN, Ghafour IM, McClure E, Barber JH. Diabetic retinopathy in the West of Scotland: Its detection and prevalence, and the cost-effectiveness of a proposed screening programme. Health Bull 1983; 41: 318-326.
16. Sculpher MJ, Buxton MJ, Ferguson BA, Humphreys JE, Altman JFB, Spiegelhalter DJ, Kirby AJ, Jacob JS, Bacon H, Dudbridge SB, Stead JW, Feest TG, Cheng H, Franklin SL, Courtney P, Talbot JF, Ahmed R, Dabbs TR. A relative cost-effectiveness analysis of different methods of screening for diabetic retinopathy. Diabetic Med 1991; 8: 644-650.
17. Singer DE, Nathan DM, Fogel HA, Schachat AP. Screening for diabetic retinopathy. Ann Intern Med 1992; 116: 660-671.
18. Brechner RJ, Cowie CC, Howie LJ, Herman WH, Will JC, Harris MI. Ophthalmic examination among adults with diagnosed diabetes. JAMA 1993; 270: 1714-1718.
19. Delcourt C, Villatte-Cathelineau B, Vauzelle-Kervroedan F, Cathelineau G, Papoz L, CODIAB-INSERM-ZENECA Pharma Study Group. Visual impairment in Type 2 diabetic patients: A multicentre study. Acta Ophthalmol Scand 1995; 73: 293-298.
20. Newcomb PA, Klein R, Masoth KM. Education to increase ophthalmologic care in older onset diabetes patients: indications from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. J Diabetes Comp 1992; 6: 211-217.
21. Will JC, German RR, Schuman E, Michael S, Kurth DM, Deeb L. Patient adherence to guidelines for diabetes eye care: Results from the Diabetic Eye Disease Follow-up Study. Am J Public Health 1994; 84: 1669-1671.
22. Agardh E, Agardh CD, Hansson-Lundblad C. The five-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabetic Med 1993; 10: 555-559.
23. Klein R. Eye-care delivery for people with diabetes. Diabetes Care 1994; 17: 614-615.
24. King H, Rewers M, WHO Ad Hoc Diabetes Reporting Group. Global estimates for prevalence of diabetes mellitus and impaired glucose toler-ance in adults. Diabetes Care 1993; 16: 157-177.
25. Wiles PG, Pearce SM, Rice PJS, Mitchell JMO. Vibration perception threshold: Influence of age, height, sex, and smoking, and calculation of accurate centile values. Diabetic Med 1991; 8: 157-161.
26. Delcourt C, Papoz L, CODIAB-INSERM-ICI Study Group. Frequency of complications in type II diabetic patients. 28th Annual Meeting of the European Diabetes Epidemiology Study Group. Cambridge, April 1993.
27. Klein R, Klein BEK, Moss SE, De Mets DL. Proteinuria in diabetes. Arch Intern Med 1988; 148: 181-186.
28. Schmitz A, Vaeth M. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabetic Med 1988; 5: 126-134.
29. Nomiyama R, Nunoi K, Tsutsu N, Satho Y, Yoshizumi H, Himeno H, Nakamura Y, Fujishima M. One-day survey of albuminuria in diabetic outpatients in Fukuoka prefecture, Japan. J Diabetes Comp 1991; 5: 155-156.
30. Gall MA, Rossing P, Skott P, Damsbo P, Vaag A, Bech K, Dejgaard A, Lauritzen M, Lauritzen E, Hougaard P, Beck-Nielsen H, Parving HH. Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1991; 34: 655-661.
31. Haffner SM, Morales PA, Gruber MK, Hazuda HP, Stern MP. Cardiovascular risk factors in non-insulin-dependent diabetic subjects with microalbuminuria. Arterioscler Thromb 1993; 13: 205-210.
32. Klein R, Klein BEK, Moss SE. Prevalence of microalbuminuria in older-onset diabetes. Diabetes Care 1993; 16: 1325-1330.
33. Klein R, Klein BEK, Moss SE, Davis MD, De Mets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is 30 years or more. Arch Ophthalmol 1989; 107: 244-249.
34. Araki A, Ito H, Hattori A, Inoue J, Sato T, Shiraki M, Orimo H. Risk factors for development of retinopathy in elderly Japanese patients with diabetes mellitus. Diabetes Care 1993; 16: 1184-1186.
35. Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC. Proliferative retinopathy in NIDDM. Incidence and risk factors in Pima Indians. Diabetes 1989; 38: 435-440.
36. Lee ET, Lee VS, Kingsley RM, Lu M, Russell D, Asal N, Wilkinson CP, Bradford RH. Diabetic retinopathy in Oklahoma Indians with NIDDM. Incidence and risk factors. Diabetes Care 1992; 15: 1620-1627.
37. Lee ET, Lee VS, Lu M, Russell D. Development of proliferative retinopathy in NIDDM. A follow-up study of American Indians in Oklahoma. Diabetes 1992; 41: 359-367.
38. Ballard DJ, Melton L, Dwyer MS, Trautman JC, Chu CP, O'Fallon WM, Palumbo PJ. Risk factors for diabetic retinopathy: A population-based study in Rochester, Minnesota. Diabetes Care 1986; 9: 334-342.
39. Mogensen CE, Chachati A, Christensen CK, Close CF, Deckert T, Hommel E, Kastrup J, Lefebvre P, Mathiesen ER, Feldt-Rasmussen B, Schmitz A, Viberti GC. Microalbuminuria: An early marker of renal involvement in diabetes. Uremia Invest 1985-1986; 9: 85-95.
40. Dyck PJ, Kratz KM, Karnes JL, Litchy WJ, Klein R, Pach JM, Wilson DM, OBrien PC, Melton LJ. The prevalence by staged severity of various types of diabetic neuropathy, retinopathy and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 1993; 43: 817-824.
41. Ziegler D, Gries FA, Mühlen H, Rathman W, Spüler M, Lessman F, DIACAN Multicenter Study Group. Prevalence and clinical correlates of cardiovascular and peripheral diabetic neuropathy in patients attending diabetes centers. Diabetes Metab 1993; 19: 143-151.
42. Consensus Statement. Report and recommendations of the San Antonio Conference on diabetic neuropathy. Diabetes 1988; 37: 1000-1004.
43. Consensus Conference. Proceedings of a consensus development conference on standardized measures in diabetic neuropathy. Diabetes Care 1992; 15: 1080-1083.
44. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329: 977-986.
45. Klein R, Klein BEK, Moss SE, Davis MD, De Mets DL. The Wisconsin Epidemiologic Study of Diabetic Complications. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 1984; 102: 527-532.
46. Hamman RF, Mayer EJ, Moo-Young GA, Hildebrandt W, Marshall JA, Baxter J. Prevalence and risk factors of diabetic retinopathy in non-hispanic whites and hispanics with NIDDM. San Luis Valley Diabetes Study. Diabetes 1989; 38: 231-327.
47. Rate RG, Knowler WC, Morse HG, Bonnell MD, McVey J, Chervenak CL, Smith MG, Pavanich G. Diabetes mellitus in Hopi and Navajo Indians. Prevalence of microvascular complications. Diabetes 1983; 32: 894-899.
48. UK Prospective Diabetes Study Group. UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance. Diabetologia 1991; 34: 877-890.
49. Knuiman MW, Welborn TA, McCann VJ, Stanton KG, Constable IJ. Prevalence of diabetic complications in relation to risk factors. Diabetes 1986; 35: 1332-1339.
50. King H, Balkau B, Zimmet P, Taylor R, Raper LR, Borger J, Heriot W. Diabetic retinopaty in Nauruans. Am J Epidemiol 1983; 117: 659-667.
51. Teuscher A, Schnell H, Wilson PWF. Incidence of diabetic retinopathy and relationship with plasma glucose and blood pressure. Diabetes Care 1988; 11: 246-251.